Merck & Co. Debt Repayments increased by 56900.0% to $1.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 54.4%, from $2.50B to $1.14B. Over 2 years (FY 2022 to FY 2025), Debt Repayments shows an upward trend with a 5.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease may indicate a focus on capital preservation or refinancing, while a significant increase signals active debt reduction or maturity fulfillment.
Represents the total cash outflows used to reduce the principal balance of short-term and long-term debt obligations. Th...
Standard across all capital-intensive industries; peers with high leverage typically show higher repayment activity.
debt_repayment| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.17B | $1.25B | $0.00 | $1.00B | $1.00M | $1.00M | $1.75B | $1.00M | $3.00M | $751.00M | $539.00M | $2.50B | $0.00 | $1.00M | $2.00M | $1.14B |
| QoQ Change | — | +7.2% | -100.0% | — | -99.9% | +0.0% | >999% | -99.9% | +200.0% | >999% | -28.2% | +363.8% | -100.0% | — | +100.0% | >999% |
| YoY Change | — | — | — | — | -99.9% | -99.9% | — | -99.9% | +200.0% | >999% | >999% | +232.9% | — | — | -99.6% | -54.4% |